Literature DB >> 7796823

Fibrinogen, fibrin and the arterial wall.

E B Smith1.   

Abstract

Virtually all plasma proteins, including fibrinogen, low density lipoprotein and lipoprotein(a), are present in normal arterial intima and in atherosclerotic lesions, and their concentrations are related to plasma concentrations. Fibrin is also a significant component of many lesions, particularly early proliferative (gelatinous) lesions, where it may be muscle cells migrate and proliferate, bind thrombin, and are a source of fibrin degradation products (FDPs), which are mitogenic. Very recent studies suggest that free a-thrombin may be present in lesions despite an apparent excess of antithrombin III, so this may promote fibrin formation within the lesion. Furthermore, fibrinolysis and FDP generation may be mediated by catheptic enzymes in addition to plasmin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796823     DOI: 10.1093/eurheartj/16.suppl_a.11

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

1.  Nutritional B vitamin deficiency alters the expression of key proteins associated with vascular smooth muscle cell proliferation and migration in the aorta of atherosclerotic apolipoprotein E null mice.

Authors:  Susan J Duthie; John H Beattie; Margaret-J Gordon; Lynn P Pirie; Fergus Nicol; Martin D Reid; Gary J Duncan; Louise Cantlay; Graham Horgan; Christopher J McNeil
Journal:  Genes Nutr       Date:  2014-12-02       Impact factor: 5.523

2.  Fibrinogen and rhegmatogenous retinal detachment: a pilot prospective study.

Authors:  Ip Theocharis
Journal:  Clin Ophthalmol       Date:  2010-02-18

3.  Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Authors:  Karsten Suhre; Christa Meisinger; Angela Döring; Elisabeth Altmaier; Petra Belcredi; Christian Gieger; David Chang; Michael V Milburn; Walter E Gall; Klaus M Weinberger; Hans-Werner Mewes; Martin Hrabé de Angelis; H-Erich Wichmann; Florian Kronenberg; Jerzy Adamski; Thomas Illig
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

Review 4.  Iron-induced fibrin in cardiovascular disease.

Authors:  Boguslaw Lipinski; Etheresia Pretorius
Journal:  Curr Neurovasc Res       Date:  2013-08       Impact factor: 1.990

Review 5.  Atherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review.

Authors:  Doron Goldberg; Soliman Khatib
Journal:  Oxid Med Cell Longev       Date:  2022-04-14       Impact factor: 7.310

6.  Associations between fibrinogen levels and the risk of cardiovascular disease and all-cause death: a cohort study from the Chin-Shan community in Taiwan.

Authors:  Cheng-Tzu Hsieh; Kuo-Liong Chien; Hsiu-Ching Hsu; Hung-Ju Lin; Ta-Chen Su; Ming-Fong Chen; Yuan-Teh Lee
Journal:  BMJ Open       Date:  2022-04-01       Impact factor: 2.692

7.  Influence of posterior vitreous detachment and type of intraocular lens on lipid peroxidation in the human vitreous.

Authors:  Raffaele Nuzzi; Alessandro Marchese; Giulia Rossana Gulino; Elisabetta Versino; Dario Ghigo
Journal:  Mol Vis       Date:  2015-09-20       Impact factor: 2.367

8.  Fibrinogen as a risk factor for premature myocardial infarction in Iranian patients: a case control study.

Authors:  Mohammad Shojaie; Morteza Pourahmad; Ahad Eshraghian; Hamid Reza Izadi; Farzan Naghshvar
Journal:  Vasc Health Risk Manag       Date:  2009-08-20

9.  Arterial ageing.

Authors:  Seung-Jun Lee; Sung-Ha Park
Journal:  Korean Circ J       Date:  2013-02-28       Impact factor: 3.243

10.  Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.

Authors:  Deshan Yuan; Ping Jiang; Pei Zhu; Sida Jia; Ce Zhang; Yue Liu; Ru Liu; Jingjing Xu; Xiaofang Tang; Xueyan Zhao; Runlin Gao; Yuejin Yang; Bo Xu; Zhan Gao; Jinqing Yuan
Journal:  Cardiovasc Diabetol       Date:  2021-07-16       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.